These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

514 related articles for article (PubMed ID: 15722162)

  • 21. Cellular uptake [correction of utake] of the Tat peptide: an endocytosis mechanism following ionic interactions.
    Vives E
    J Mol Recognit; 2003; 16(5):265-71. PubMed ID: 14523939
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of cell penetrating peptides fused to elastin-like polypeptide for drug delivery.
    Massodi I; Bidwell GL; Raucher D
    J Control Release; 2005 Nov; 108(2-3):396-408. PubMed ID: 16157413
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Re-evaluating the role of strongly charged sequences in amphipathic cell-penetrating peptides: a fluorescence study using Pep-1.
    Henriques ST; Costa J; Castanho MA
    FEBS Lett; 2005 Aug; 579(20):4498-502. PubMed ID: 16083883
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Study of uptake of cell penetrating peptides and their cargoes in permeabilized wheat immature embryos.
    Chugh A; Eudes F
    FEBS J; 2008 May; 275(10):2403-14. PubMed ID: 18397318
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vivo biodistribution and efficacy of peptide mediated delivery.
    Järver P; Mäger I; Langel Ü
    Trends Pharmacol Sci; 2010 Nov; 31(11):528-35. PubMed ID: 20828841
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Delivery of proteins and nucleic acids using a non-covalent peptide-based strategy.
    Deshayes S; Morris M; Heitz F; Divita G
    Adv Drug Deliv Rev; 2008 Mar; 60(4-5):537-47. PubMed ID: 18037526
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cell-penetrating peptides as delivery vehicles for biology and medicine.
    Stewart KM; Horton KL; Kelley SO
    Org Biomol Chem; 2008 Jul; 6(13):2242-55. PubMed ID: 18563254
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thermodynamics of lipid interactions with cell-penetrating peptides.
    Sauder R; Seelig J; Ziegler A
    Methods Mol Biol; 2011; 683():129-55. PubMed ID: 21053127
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chances and pitfalls of cell penetrating peptides for cellular drug delivery.
    Tréhin R; Merkle HP
    Eur J Pharm Biopharm; 2004 Sep; 58(2):209-23. PubMed ID: 15296950
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biological responses towards cationic peptides and drug carriers.
    Verdurmen WP; Brock R
    Trends Pharmacol Sci; 2011 Feb; 32(2):116-24. PubMed ID: 21167610
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel human-derived cell-penetrating peptides for specific subcellular delivery of therapeutic biomolecules.
    De Coupade C; Fittipaldi A; Chagnas V; Michel M; Carlier S; Tasciotti E; Darmon A; Ravel D; Kearsey J; Giacca M; Cailler F
    Biochem J; 2005 Sep; 390(Pt 2):407-18. PubMed ID: 15859953
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Free uptake of cell-penetrating peptides by fission yeast.
    Parenteau J; Klinck R; Good L; Langel U; Wellinger RJ; Elela SA
    FEBS Lett; 2005 Aug; 579(21):4873-8. PubMed ID: 16111683
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cell-penetrating peptides: a comparative membrane toxicity study.
    Saar K; Lindgren M; Hansen M; Eiríksdóttir E; Jiang Y; Rosenthal-Aizman K; Sassian M; Langel U
    Anal Biochem; 2005 Oct; 345(1):55-65. PubMed ID: 16137634
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cell-penetrating peptides are excluded from the mitochondrial matrix.
    Ross MF; Murphy MP
    Biochem Soc Trans; 2004 Dec; 32(Pt 6):1072-4. PubMed ID: 15506968
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The cell penetrating peptides pVEC and W2-pVEC induce transformation of gel phase domains in phospholipid bilayers without affecting their integrity.
    Herbig ME; Assi F; Textor M; Merkle HP
    Biochemistry; 2006 Mar; 45(11):3598-609. PubMed ID: 16533042
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recent progress of cell-penetrating peptides as new carriers for intracellular cargo delivery.
    Wang F; Wang Y; Zhang X; Zhang W; Guo S; Jin F
    J Control Release; 2014 Jan; 174():126-36. PubMed ID: 24291335
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cell transduction pathways of transportans.
    Padari K; Säälik P; Hansen M; Koppel K; Raid R; Langel U; Pooga M
    Bioconjug Chem; 2005; 16(6):1399-410. PubMed ID: 16287236
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Penetration without cells: membrane translocation of cell-penetrating peptides in the model giant plasma membrane vesicles.
    Säälik P; Niinep A; Pae J; Hansen M; Lubenets D; Langel Ü; Pooga M
    J Control Release; 2011 Jul; 153(2):117-25. PubMed ID: 21420454
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cationic cell-penetrating peptides interfere with TNF signalling by induction of TNF receptor internalization.
    Fotin-Mleczek M; Welte S; Mader O; Duchardt F; Fischer R; Hufnagel H; Scheurich P; Brock R
    J Cell Sci; 2005 Aug; 118(Pt 15):3339-51. PubMed ID: 16079278
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acid wash in determining cellular uptake of Fab/cell-permeating peptide conjugates.
    Kameyama S; Horie M; Kikuchi T; Omura T; Tadokoro A; Takeuchi T; Nakase I; Sugiura Y; Futaki S
    Biopolymers; 2007; 88(2):98-107. PubMed ID: 17252560
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.